Singapore- Tocagen enters into a license agreement with ApolloBio affiliate Beijing Apollo Venus Biomedical Te...
Prenetics, a HongKong-based genetic testing and digital health company, has announced acquisition of DNAFit, a UK-based ...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced preliminary results of a phase...
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company...
JHL Biotech recently announced that the China Food and Drug Administration (CFDA) have accepted for review JHL's Clinica...
Royal Philips, a global leader in health technology, and Digital China Health, the largest provider of cloud-based healt...
AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK.&...
CMB International Capital Corporation Ltd, a wholly-owned subsidiary of China Merchants Bank, recently led a $65 million...
Morphotek Inc., a subsidiary of Eisai Inc., has licensed its eribulin-linker payload to Bliss Biopharmaceutical Co., Ltd...
China-based BeiGene, , a commercial-stage biopharmaceutical company focused on developing and commercializing inno...
Ubiquigent Limited has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for t...
CICC Capital Management Company Limited, a wholly-owned subsidiary of China International Capital Corporation Limited (C...
Eli Lilly has offloaded three small molecule therapeutic candidates for the potential treatment of non-alcoholic steatoh...
Equashield a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that it will be l...
China based CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) provid...
Nabriva Therapeutics, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-i...
Fresenius Medical Care, the world's largest provider of dialysis products and services, has announced a new partnership ...
Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes,...
